학술논문
Erratum: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT) (Clin Cancer Res (2020) 26 (1574-1585) DOI: 10.1158/1078-0432.CCR-19-3053)
Document Type
Erratum
Author
Robertson, J.F.R.; Coleman, R.E.; Cheung, K.-L.; Evans, A.; Holcombe, C.; Skene, A.; Rea, D.; Ahmed, S.; Jahan, A.; Horgan, K.; Rauchhaus, P.; Littleford, R.; Amy Cheung, S.Y.; Cullberg, M.; de Bruin, E.C.; Koulai, L.; Lindemann, J.P.O.; Pass, M.; Rugman, P.; Schiavon, G.; Deb, R.; Finlay, P.; Foxley, A.; Gee, J.M.W.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 December 2022, 28(24):5469)
Subject
Language
English
ISSN
15573265
10780432
10780432